Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection

Clinical trial NCT06508138 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06508138
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

HPV 16 Infection HPV-Related Carcinoma Recurrence Metastatic Cancer

Start date: 2023-10-18
Primary completion: 2027-04-18
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.